Dual Bronchodilator Therapy: A Review

Science Press Release Distribution Services

Dual Bronchodilator Therapy: A Review

February 6, 2020 Medicine and Medical Science 0

Inhaled bronchodilators with or without inhaled steroids (IGCs) are the mainstay of pharmacological treatment for stable obstructive airway diseases, including beta2-agonists and muscarinic antagonists. Long-acting muscarinic antagonist bronchodilators (LAMA) and long-acting β2-agonists (LABA) are the treatment of choice for moderate to severe chronic obstructive pulmonary disease (COPD). Also some studies have demonstrated the benefit of LAMA in the treatment of difficult-to-control asthma and the potential use in asthma-COPD overlap (ACO). Control of airway tone in health and disease states, cholinergic and adrenergic receptors, signaling, molecular biology of mediators, and airway muscle contraction / relaxation mechanisms are reviewed concisely and as they may be handled pharmacologically. Subsequently, the evidence of the role of the LABA / LAMA combination in the aforementioned entities, their complementary mechanisms of action and other alternative mechanisms of action as well as potential deleterious effects is discussed.

For more information contact author

Alcibey Alvarado
Internal Medicine and Neumology, Clínica de Diagnóstico Médico, San José, Costa Rica.
E-mail: [email protected]

View Volume: http://bp.bookpi.org/index.php/bpi/catalog/book/135

 

Leave a Reply

Your email address will not be published. Required fields are marked *